M.D. Anderson Cancer Center: Lung Neoplasms trials

The registry lists 149 Lung Neoplasms studies with M.D. Anderson Cancer Center as lead sponsor. 22 are open to participants now and 38 have results posted.

Early Phase 1 1Phase 1 37Phase 2 71Phase 3 5No phase 55(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot ProjectCompletedNCT02459002
• Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesTerminatedNCT02419495Phase 1
• PCORI-CER-1306-03385 Lung Cancer Screening Readiness StudyStatus unknownNCT02292485
• Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung CancerCompletedNCT02225405Phase 1
• Yoga Program for Lung Cancer Patients and CaregiversCompletedNCT02196844Not applicable
• Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT)WithdrawnNCT02044601Phase 1/2
• Hatha Yoga in Lung Cancer CouplesTerminatedNCT01952860Not applicable
• Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation TherapyCompletedNCT01808677
• Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT01562301Phase 1
• Natural History of Lung Nodules Seen on CT Scans From Participants at High-Risk of Developing Lung CancerCompletedNCT01540552
• Clearance Of Mucus In Stents (COMIS)CompletedNCT01370278Not applicable
• Study of 18F-Fluoro-PEG6-IPQACompletedNCT01320059Phase 1
• Study of Hypofractionated Proton Radiation Therapy in Thoracic MalignanciesTerminatedNCT01165658Phase 1
• Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01083589Phase 2
• Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)WithdrawnNCT01048983Phase 1/2
• Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus TumorsCompletedNCT00984997Phase 2
• 4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung MetastasisCompletedNCT00862680
• Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude GatingCompletedNCT00843219
• Utility of Endobronchial Ultrasound Guided Needle Biopsy in Early Stage Non- Small Cell Lung Cancer (NSCLC)CompletedNCT00832715Phase 1/2
• Topical Cyclosporine vs. Placebo for Epiphora Associated With DocetaxelWithdrawnNCT00824811Phase 2
• Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00745732Phase 1
• Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer SettingActive, not recruitingNCT00618553Phase 2
• Endobronchial Ultrasound Versus Mediastinoscopy in Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00559611Not applicable
• Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung CancerTerminatedNCT00543335Phase 1
• BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00533585Phase 1
• 3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation TherapyCompletedNCT00520702Phase 2
• Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)Active, not recruitingNCT00508443Phase 1/2
• Thermal Signature of Patients Undergoing Radiation TherapyWithdrawnNCT00508313
• Vibration Response Imaging (VRI) in Lung Cancer PatientsCompletedNCT00506467
• Interactive Voice Response System (IVRS) for Managing Symptoms of Patients Following Thoracic SurgeryCompletedNCT00505024Not applicable
• Gene Polymorphisms and Symptoms in Lung Cancer PatientsCompletedNCT00504374
• Measurement of Pain and Other Symptoms of Non-Small Cell Lung Cancer (NSCLC) Patients Following Thoracic SurgeryCompletedNCT00501319
• Tracking of Respiratory-Induced Tumor Motion Using Implanted FiducialsCompletedNCT00500513Not applicable
• SRS Study in Patients With Non-Small Cell Lung CancerCompletedNCT00489008Phase 2
• Six-Minute Walk Test in Patients at High Risk for Complications From Lung ResectionStatus unknownNCT00450125
• Longitudinal Study of Multiple Symptoms in Advanced Lung CancerCompletedNCT00422500
• Respiratory Tumor and Normal Tissue MotionCompletedNCT00415675
• Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC)WithdrawnNCT00411593Phase 1/2
• BATTLE Program: Umbrella Protocol for Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00409968
• Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNCT00352391
• CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00346801Phase 1
• Computer-Assisted Counseling in Helping African American Smokers Stop SmokingCompletedNCT00310141Not applicable
• Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During PregnancyCompletedNCT00310115
• Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid TumorsCompletedNCT00078845Phase 2
• Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung CancerCompletedNCT00059605Phase 1
• Iressa/Docetaxel in Non-Small-Cell Lung CancerWithdrawnNCT00048087Phase 2
• Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung CancerCompletedNCT00043823Phase 1/2
• Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00016367Phase 2
• Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung CancerWithdrawnNCT00003599Phase 3